dLife Diabetes Newswire: FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes; Turning ‘Bad’ Fat Into ‘Good’: a Future Treatment for Obesity?; Structured Exercise Training Associated with Improved Glycemic Control for Patients with Diabetes; More.
Diabetes support groups are happening nationwide. Get the details here or submit your own event to the dLife Calendar today.
Diabetes support groups are happening nationwide. Get the details here or submit your own event to the dLife Calendar today.
No comments:
Post a Comment